CN117045851A - Antibacterial liquid spray dressing - Google Patents
Antibacterial liquid spray dressing Download PDFInfo
- Publication number
- CN117045851A CN117045851A CN202210487369.4A CN202210487369A CN117045851A CN 117045851 A CN117045851 A CN 117045851A CN 202210487369 A CN202210487369 A CN 202210487369A CN 117045851 A CN117045851 A CN 117045851A
- Authority
- CN
- China
- Prior art keywords
- parts
- liquid spray
- spray dressing
- weight
- dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 37
- 239000007921 spray Substances 0.000 title claims abstract description 30
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 18
- -1 methyl cyclodextrin Chemical compound 0.000 claims abstract description 28
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 13
- 229920001661 Chitosan Polymers 0.000 claims abstract description 13
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 13
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims abstract description 13
- 229930182566 Gentamicin Natural products 0.000 claims abstract description 13
- AXFYFNCPONWUHW-UHFFFAOYSA-N beta-hydroxy-beta-methyl butyric acid Natural products CC(C)(O)CC(O)=O AXFYFNCPONWUHW-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 13
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 13
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims abstract description 13
- 229960002518 gentamicin Drugs 0.000 claims abstract description 13
- NODGRWCMFMEGJH-UHFFFAOYSA-N p-ethylacetophenone Chemical compound CCC1=CC=C(C(C)=O)C=C1 NODGRWCMFMEGJH-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229960000707 tobramycin Drugs 0.000 claims abstract description 13
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 claims abstract description 13
- 235000010956 sodium stearoyl-2-lactylate Nutrition 0.000 claims abstract description 10
- KNYAZNABVSEZDS-UHFFFAOYSA-M sodium;2-octadecanoyloxypropanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C([O-])=O KNYAZNABVSEZDS-UHFFFAOYSA-M 0.000 claims abstract description 10
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims abstract description 6
- HDKKRASBPHFULQ-UHFFFAOYSA-N 3-Hydroxy-2-pentanone Chemical compound CCC(O)C(C)=O HDKKRASBPHFULQ-UHFFFAOYSA-N 0.000 claims description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- YFNONBGXNFCTMM-UHFFFAOYSA-N butoxybenzene Chemical compound CCCCOC1=CC=CC=C1 YFNONBGXNFCTMM-UHFFFAOYSA-N 0.000 claims description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- OMNKZBIFPJNNIO-UHFFFAOYSA-N n-(2-methyl-4-oxopentan-2-yl)prop-2-enamide Chemical compound CC(=O)CC(C)(C)NC(=O)C=C OMNKZBIFPJNNIO-UHFFFAOYSA-N 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- 230000000845 anti-microbial effect Effects 0.000 claims 6
- 239000004599 antimicrobial Substances 0.000 claims 6
- 239000003242 anti bacterial agent Substances 0.000 abstract description 4
- 239000002131 composite material Substances 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 abstract description 3
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 abstract description 3
- GJYCVCVHRSWLNY-UHFFFAOYSA-N 2-butylphenol Chemical compound CCCCC1=CC=CC=C1O GJYCVCVHRSWLNY-UHFFFAOYSA-N 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 description 15
- 208000027418 Wounds and injury Diseases 0.000 description 15
- 230000006870 function Effects 0.000 description 4
- 230000000474 nursing effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000001266 bandaging Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- YZNWXXJZEDHRKB-UHFFFAOYSA-N octadecyl 2-hydroxypropanoate;sodium Chemical compound [Na].CCCCCCCCCCCCCCCCCCOC(=O)C(C)O YZNWXXJZEDHRKB-UHFFFAOYSA-N 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides an antibacterial liquid spray dressing. Comprises the following components in parts by weight: 20-28 parts of chitosan, 8-12 parts of carboxymethyl cellulose, 4-6 parts of methyl cyclodextrin, 1-3 parts of beta-hydroxy isovaleric acid, 1-3 parts of pyrrolidone sodium carboxylate, 1-3 parts of butyl hydroxy benzoate, 2-4 parts of p-ethyl acetophenone, 0.2-0.4 part of tobramycin, 0.2-0.6 part of gentamicin and 1-2 parts of sodium stearoyl lactate. The invention introduces the antibacterial agent with composite components on the premise of not affecting the performance of the dressing, and integrates the antibacterial agent with the composite formula, thereby constructing a brand new dressing formula. Specifically, the invention takes chitosan, carboxymethyl cellulose and methyl cyclodextrin as main components, and introduces beta-hydroxy isovaleric acid, sodium pyrrolidone carboxylate, butyl hydroxy benzene, p-ethyl acetophenone and other components to improve the curing effect, and simultaneously, tobramycin and gentamicin are added, thereby safely achieving the broad-spectrum antibacterial effect. The invention has reasonable formula and good antibacterial effect, and has outstanding advantage technology.
Description
Technical Field
The invention relates to the technical field of liquid dressing, in particular to an antibacterial liquid spray dressing.
Background
The liquid dressing is a nursing agent for skin wound surface, and forms a protective layer on the surface of the wound surface to play a physical barrier role, so that the nursing agent is used for nursing superficial wound surface and surrounding skin. The liquid dressing has the function of disinfection, can directly act on pathogens, has the function of inhibiting most bacteria, viruses and protozoa, including staphylococcus aureus, escherichia coli, hemolytic streptococcus and the like, and can form a layer of protective film to protect wounds when being sprayed on wound surfaces, and simultaneously isolate the wounds from the outside, prevent the invasion of external pathogens and kill the bacteria around the wounds. Can be used for treating wound of abdomen and perineum, and has effects of promoting wound healing and preventing infection.
In the prior art, a protective film is formed on the surface of a wound when the liquid auxiliary material is sprayed on the surface of the wound, and the protective film can play a role in sterilizing, in addition, a moist environment can be formed on the surface of the wound, so that the healing of the wound can be promoted, under the traditional concept, people usually consider that the wound should be kept in a dry environment, otherwise, the wound is easy to inflame, but the moist environment is easier to promote the healing of the wound as the medical research finds, and the moist environment can also lighten the pain of the wound, so that the liquid dressing gradually replaces the traditional bandaging mode, can be accepted by people more easily, and is convenient to use. Currently, conventional liquid dressings have made great progress in promoting wound healing and the like, but their antibacterial efficacy has yet to be improved.
Disclosure of Invention
Aiming at the technical defects of the prior art, the invention provides an antibacterial liquid spray dressing to solve the technical problem that the antibacterial property of the conventional liquid dressing needs to be improved.
In order to achieve the technical purpose, the invention adopts the following technical scheme:
an antibacterial liquid spray dressing comprises the following components in parts by weight: 20-28 parts of chitosan, 8-12 parts of carboxymethyl cellulose, 4-6 parts of methyl cyclodextrin, 1-3 parts of beta-hydroxy isovaleric acid, 1-3 parts of pyrrolidone sodium carboxylate, 1-3 parts of butyl hydroxy benzoate, 2-4 parts of p-ethyl acetophenone, 0.2-0.4 part of tobramycin, 0.2-0.6 part of gentamicin and 1-2 parts of sodium stearoyl lactate.
Preferably, the liquid spray dressing further comprises 1 to 3 parts by weight of xylitol fatty acid ester.
Preferably, the liquid spray dressing further comprises 2 to 4 parts by weight of L-ureido alanine.
Preferably, the liquid spray dressing further comprises 1 to 5 parts by weight of diacetone acrylamide.
Preferably, the liquid spray dressing further comprises 1 to 3 parts by weight of acetyl n-propanol.
Preferably, the liquid spray dressing comprises the following components in parts by weight: 24 parts of chitosan, 10 parts of carboxymethyl cellulose, 5 parts of methyl cyclodextrin, 2 parts of beta-hydroxy isovaleric acid, 2 parts of pyrrolidone sodium carboxylate, 2 parts of butyl oxybenzene, 3 parts of p-ethyl acetophenone, 0.3 part of tobramycin, 0.4 part of gentamicin and 1.5 parts of sodium stearoyl lactate.
Preferably, the liquid spray dressing comprises the following components in parts by weight: 24 parts of chitosan, 10 parts of carboxymethyl cellulose, 5 parts of methyl cyclodextrin, 2 parts of beta-hydroxy isovaleric acid, 2 parts of pyrrolidone sodium carboxylate, 2 parts of butyl hydroxybenzoate, 3 parts of p-ethyl acetophenone, 0.3 part of tobramycin, 0.4 part of gentamicin, 1.5 parts of sodium stearoyl lactate, 2 parts of xylitol fatty acid ester, 3 parts of L-ureidoalanine, 3 parts of diacetone acrylamide and 2 parts of acetyl n-propanol.
The invention provides an antibacterial liquid spray dressing. According to the technical scheme, the antibacterial agent with the composite components is introduced on the premise of not affecting the performance of the dressing, and the antibacterial agent is integrated by adopting a composite formula, so that a brand new dressing formula is constructed. Specifically, the invention takes chitosan, carboxymethyl cellulose and methyl cyclodextrin as main components, and introduces beta-hydroxy isovaleric acid, sodium pyrrolidone carboxylate, butyl hydroxy benzene, p-ethyl acetophenone and other components to improve the curing effect, and simultaneously, tobramycin and gentamicin are added, thereby safely achieving the broad-spectrum antibacterial effect. The invention has reasonable formula and good antibacterial effect, and has outstanding advantage technology.
Detailed Description
Hereinafter, embodiments of the present invention will be described in detail. In order to avoid unnecessary detail, well-known structures or functions will not be described in detail in the following embodiments. Approximating language, as used in the following examples, may be applied to create a quantitative representation that could permissibly vary without resulting in a change in the basic function. Unless defined otherwise, technical and scientific terms used in the following examples have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
Example 1
An antibacterial liquid spray dressing comprises the following components in parts by weight: 24 parts of chitosan, 10 parts of carboxymethyl cellulose, 5 parts of methyl cyclodextrin, 2 parts of beta-hydroxy isovaleric acid, 2 parts of pyrrolidone sodium carboxylate, 2 parts of butyl hydroxybenzoate, 3 parts of p-ethyl acetophenone, 0.3 part of tobramycin, 0.4 part of gentamicin, 1.5 parts of sodium stearoyl lactate, 2 parts of xylitol fatty acid ester, 3 parts of L-ureidoalanine, 3 parts of diacetone acrylamide and 2 parts of acetyl n-propanol.
Example 2
An antibacterial liquid spray dressing comprises the following components in parts by weight: 24 parts of chitosan, 10 parts of carboxymethyl cellulose, 5 parts of methyl cyclodextrin, 2 parts of beta-hydroxy isovaleric acid, 2 parts of pyrrolidone sodium carboxylate, 2 parts of butyl oxybenzene, 3 parts of p-ethyl acetophenone, 0.3 part of tobramycin, 0.4 part of gentamicin and 1.5 parts of sodium stearoyl lactate
Example 3
An antibacterial liquid spray dressing comprises the following components in parts by weight: 20 parts of chitosan, 8 parts of carboxymethyl cellulose, 4 parts of methyl cyclodextrin, 1 part of beta-hydroxy isovaleric acid, 1 part of pyrrolidone sodium carboxylate, 1 part of butyl oxybenzene, 2 parts of p-ethyl acetophenone, 0.2 part of tobramycin, 0.2 part of gentamicin and 1 part of sodium stearoyl lactate.
Example 4
An antibacterial liquid spray dressing comprises the following components in parts by weight: 28 parts of chitosan, 12 parts of carboxymethyl cellulose, 6 parts of methyl cyclodextrin, 3 parts of beta-hydroxy isovaleric acid, 3 parts of sodium pyrrolidone carboxylate, 3 parts of butyl oxybenzene, 4 parts of p-ethyl acetophenone, 0.4 part of tobramycin, 0.6 part of gentamicin and 2 parts of sodium stearyl lactate.
The foregoing describes the embodiments of the present invention in detail, but the description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modification, equivalent replacement, improvement, etc. made within the scope of the present invention should be included in the protection scope of the present invention.
Claims (7)
1. An antibacterial liquid spray dressing is characterized by comprising the following components in parts by weight: 20-28 parts of chitosan, 8-12 parts of carboxymethyl cellulose, 4-6 parts of methyl cyclodextrin, 1-3 parts of beta-hydroxy isovaleric acid, 1-3 parts of pyrrolidone sodium carboxylate, 1-3 parts of butyl hydroxy benzoate, 2-4 parts of p-ethyl acetophenone, 0.2-0.4 part of tobramycin, 0.2-0.6 part of gentamicin and 1-2 parts of sodium stearoyl lactate.
2. An antimicrobial liquid spray dressing according to claim 1, wherein the liquid spray dressing further comprises 1 to 3 parts by weight of xylitol fatty acid ester.
3. An antimicrobial liquid spray dressing according to claim 1, wherein the liquid spray dressing further comprises 2 to 4 parts by weight of L-ureido alanine.
4. An antimicrobial liquid spray dressing according to claim 1, wherein the liquid spray dressing further comprises 1 to 5 parts by weight of diacetone acrylamide.
5. An antimicrobial liquid spray dressing according to claim 1, wherein the liquid spray dressing further comprises 1 to 3 parts by weight of acetyl n-propanol.
6. An antimicrobial liquid spray dressing according to claim 1, characterized in that the liquid spray dressing consists of the following components in parts by weight: 24 parts of chitosan, 10 parts of carboxymethyl cellulose, 5 parts of methyl cyclodextrin, 2 parts of beta-hydroxy isovaleric acid, 2 parts of pyrrolidone sodium carboxylate, 2 parts of butyl oxybenzene, 3 parts of p-ethyl acetophenone, 0.3 part of tobramycin, 0.4 part of gentamicin and 1.5 parts of sodium stearoyl lactate.
7. An antimicrobial liquid spray dressing according to claim 1, characterized in that the liquid spray dressing consists of the following components in parts by weight: 24 parts of chitosan, 10 parts of carboxymethyl cellulose, 5 parts of methyl cyclodextrin, 2 parts of beta-hydroxy isovaleric acid, 2 parts of pyrrolidone sodium carboxylate, 2 parts of butyl hydroxybenzoate, 3 parts of p-ethyl acetophenone, 0.3 part of tobramycin, 0.4 part of gentamicin, 1.5 parts of sodium stearoyl lactate, 2 parts of xylitol fatty acid ester, 3 parts of L-ureidoalanine, 3 parts of diacetone acrylamide and 2 parts of acetyl n-propanol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210487369.4A CN117045851A (en) | 2022-05-06 | 2022-05-06 | Antibacterial liquid spray dressing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210487369.4A CN117045851A (en) | 2022-05-06 | 2022-05-06 | Antibacterial liquid spray dressing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117045851A true CN117045851A (en) | 2023-11-14 |
Family
ID=88661350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210487369.4A Withdrawn CN117045851A (en) | 2022-05-06 | 2022-05-06 | Antibacterial liquid spray dressing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117045851A (en) |
-
2022
- 2022-05-06 CN CN202210487369.4A patent/CN117045851A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hilton et al. | Wound dressings in diabetic foot disease | |
| EP2763665B1 (en) | Antimicrobial compositions and methods employing same | |
| Lawrence | Dressings and wound infection | |
| CN110559467B (en) | Micro-nano magnesium hydride wound dressing with antibacterial and anti-inflammatory effects | |
| CN103271794B (en) | Biological antibiotic based on bedsore wound is applied ointment or plaster | |
| CN105999362A (en) | Medical composite alginate dressing containing antibacterial drug and preparation method thereof | |
| CN103656734A (en) | Wound-healing dressing film | |
| US20120148520A1 (en) | Organic Iodine Complex Durable Barrier With Antimicrobial Preparations | |
| Wu et al. | Research progress on negative pressure wound therapy with instillation in the treatment of orthopaedic wounds | |
| Jacobsen | Update on wound dressings: indications and best use | |
| CN111166932B (en) | Liquid wound spray dressing and preparation method thereof | |
| CN117045851A (en) | Antibacterial liquid spray dressing | |
| CN109432483B (en) | Medical dressing for accelerating wound healing and preparation method and application thereof | |
| Ip | Antimicrobial dressings | |
| Khan | Honey compared with silver sulphadiazine as burn wound dressing | |
| CN115581797A (en) | Liquid dressing for promoting wound surface healing | |
| Fletes-Vargas et al. | Natural Hydrogels as Wound Dressing for Skin Wound-Healing Applications | |
| CN114618012A (en) | Liquid dressing with skin care effect | |
| Kingsley et al. | Suprasorb® X+ PHMB: antimicrobial and hydrobalance action in a new wound dressing | |
| Raducu et al. | Use of polyhexanidine in treating chronic wounds | |
| Bishop et al. | Using antimicrobial dressings to treat infected wounds | |
| Rizani | Modern Wound Dressing for Wound Infection: An Overview | |
| CN111001030B (en) | Medical dressing and preparation method and application thereof | |
| White | The use of topical antimicrobials in wound bioburden control | |
| Andrews | Dressings in burn wound management |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20231114 |